2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one

C28H31N5O2 — CID 118509527

IUPAC2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one
SMILESCc1nc(-c2nc3cc4c(cc3n2[C@@H](C)c2ccccc2)N(C(C)C)C(=O)C4(C)C)cn(C)c1=O
InChIInChI=1S/C28H31N5O2/c1-16(2)32-23-14-24-21(13-20(23)28(5,6)27(32)35)30-25(22-15-31(7)26(34)17(3)29-22)33(24)18(4)19-11-9-8-10-12-19/h8-16,18H,1-7H3/t18-/m0/s1
InChIKeyYQRZARPAWNRNAI-SFHVURJKSA-N
MW469.59 g/mol
LogP4.75
Rot. Bonds4

About 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one

2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one (PubChem CID 118509527) has the molecular formula C28H31N5O2 and a molecular weight of 469.59 g/mol. Its IUPAC name is 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one.

Molecular Properties

Compound Name2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one
PubChem CID118509527
Molecular FormulaC28H31N5O2
Molecular Weight469.59 g/mol
Exact Mass469.25
IUPAC Name2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one
SMILESCc1nc(-c2nc3cc4c(cc3n2[C@@H](C)c2ccccc2)N(C(C)C)C(=O)C4(C)C)cn(C)c1=O
InChIInChI=1S/C28H31N5O2/c1-16(2)32-23-14-24-21(13-20(23)28(5,6)27(32)35)30-25(22-15-31(7)26(34)17(3)29-22)33(24)18(4)19-11-9-8-10-12-19/h8-16,18H,1-7H3/t18-/m0/s1
InChIKeyYQRZARPAWNRNAI-SFHVURJKSA-N
XLogP4.75
TPSA73.02 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500469.59
LogP ≤ 54.75
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one?
The IUPAC name of 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one (CID 118509527) is 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one.
What is the SMILES notation for 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one?
The canonical SMILES for 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one is Cc1nc(-c2nc3cc4c(cc3n2[C@@H](C)c2ccccc2)N(C(C)C)C(=O)C4(C)C)cn(C)c1=O.
What is the InChIKey of 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one?
The InChIKey is YQRZARPAWNRNAI-SFHVURJKSA-N. The full InChI is InChI=1S/C28H31N5O2/c1-16(2)32-23-14-24-21(13-20(23)28(5,6)27(32)35)30-25(22-15-31(7)26(34)17(3)29-22)33(24)18(4)19-11-9-8-10-12-19/h8-16,18H,1-7H3/t18-/m0/s1.
What are the key properties of 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one?
2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one has a molecular weight of 469.59 g/mol, XLogP of 4.75, 4 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4,6-dimethyl-5-oxopyrazin-2-yl)-7,7-dimethyl-3-[(1S)-1-phenylethyl]-5-propan-2-ylpyrrolo[3,2-f]benzimidazol-6-one is sourced from PubChem (CID 118509527), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).